EEG biomarkers in major depressive disorder: Discriminative power and prediction of treatment response

By Olbrich Sebastian   Arns Martijn  

International Review of Psychiatry, Vol. 25, Iss. 5, 2013-10 ,pp. : 604-618

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram in major depressive disorder: clinical benefits and cost effectiveness versus citalopram

By Lançon Christophe   Verpillat Patrice   Annemans Lieven   Despiegel Nicolas   François Clément  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 1, 2007-01 ,pp. : 44-52

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A Description of Next-Step Switching Versus Augmentation Practices for Outpatients with Treatment-Resistant Major Depressive Disorder Enrolled in an Academic Specialty Clinic

By Papakostas George   Petersen Timothy   Green Cassandra   Iosifescu Dan   Yeung Albert   Nierenberg Andrew   Fava Maurizio   Posternak Michael  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 17, Iss. 3, 2005-07 ,pp. : 161-165

Informa Healthcare

Access to resources Recommend Favorite

Anticonvulsants in the Treatment of Major Depressive Disorder: An Overview

By Vigo Daniel   Baldessarini Ross  

Harvard Review of Psychiatry, Vol. 17, Iss. 4, 2009-08 ,pp. : 231-241

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Escitalopram in the Long-term Treatment of Major Depressive Disorder

By Wade Alan   Despiegel Nicolas   Heldbo Reines Elin  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 2, 2006-05 ,pp. : 83-89

Informa Healthcare

Access to resources Recommend Favorite